Bank of America’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bank of America’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-215,000	Closed	-$9.77M	–	7427
2019 Q4	$9.77M	Buy	+215,000	New	+$10.2M	﹤0.01%	2575
2015 Q1	–	Sell	-380	Closed	-$13K	–	7726
2014 Q4	$13K	Sell	380 -1,690	-82%	-$68.6K	﹤0.01%	6974
2014 Q3	$87K	Sell	2,070 -1,570	-43%	-$70.1K	﹤0.01%	6115
2014 Q2	$213K	Sell	3,640 -50,600	-93%	-$3.19M	﹤0.01%	5502
2014 Q1	$3.42M	Sell	54,240 -9,470	-15%	-$628K	﹤0.01%	2736
2013 Q4	$3.73M	Sell	63,710 -3,820	-6%	-$200K	﹤0.01%	2743
2013 Q3	$3.56M	Sell	67,530 -10,120	-13%	-$680K	﹤0.01%	2701
2013 Q2	$5.98M	Buy	+77,650	New	+$6.34M	﹤0.01%	2147

Bank of America's ARNA Position: Q1 2022 in Review

Bank of America sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 115,252 shares — an estimated $10.7M sold.

Bank of America first reported a position in ARNA in Q2 2013 and held it in 35 quarters. The position peaked at $11.1M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Bank of America reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Bank of America sold 115,252 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $10.7M.
Bank of America first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 35 quarters.
Bank of America's Arena Pharmaceuticals Inc position peaked at $11.1M in Q2 2019.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Bank of America's 13F filing for Q1 2022, filed 16 May 2022.